(Q43632858)

25 November 2017

title

Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction (English)

1 reference

25 November 2017

0 references

Morris JC

1

1 reference

25 November 2017

publication date

1 January 2001

1 reference

25 November 2017

published in

Clinical Therapeutics

1 reference

25 November 2017

volume

23 Suppl A

1 reference

25 November 2017

page(s)

A1-2

1 reference

Cholinesterase inhibitors for Alzheimer's disease.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980161-2

7 January 2021

10.1016/S0149-2918(01)80161-2

Identifiers

DOI

1 reference

25 November 2017

1 reference